Anzeige
Mehr »
Donnerstag, 22.01.2026 - Börsentäglich über 12.000 News
Gold über 4.862 USD - auf dem Weg zu 5.000 USD: Warum A2 Gold jetzt in eine neue Liga aufsteigt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Technology

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MiDavos26: Trump says tariff threats helped fix US drug pricing 'unfairness'
MiPfizer and Novavax ink $530m vaccine delivery licensing deal
MiBMS and Microsoft partner for AI-based lung cancer detection
MiNovo Nordisk and Aspect Biosystems advance partnership for diabetes therapies
DiShionogi expands ViiV Healthcare stake by $2.13bn as Pfizer sells up
DiGSK scoops up RAPT Therapeutics for $2.2bn
DiDeepHow introduces PharmaCloud for pharmaceutical manufacturers
DiiRegene receives FDA RMAT designation for NouvNeu001 to treat Parkinson's
MoUK's pharma outlook buoyed by trans-Atlantic trade policies
MoCompounder sues Lilly and Novo for suppressing GLP-1RA competition
MoAstraZeneca to acquire China rights for AbelZeta's CAR-T therapy
MoFDA grants Novartis' ianalumab breakthrough therapy status for Sjögren's disease
FrFDA prevails over EMA in 2025 novel drug approvals
FrJ&J's Caplyta doubles remission rate in MDD patients
FrUK's MHRA gives high-dose Wegovy the go-ahead in obesity
FrInterAx and Alveus collaborate on small-molecule metabolic treatment
FrAgenus and Zydus complete $141m BOT+BAL immunotherapy collaboration deal
15.01.JPM26: Fujifilm's modular manufacturing answer to pharma tariffs
15.01.JPM26: Solid Biosciences banks on its AAV capsid to catalyse gene therapy success
15.01.Novo Nordisk Foundation pours $850m into European life sciences economy
15.01.JPM26: Jazz sells PRV for $200m, targets deals in 2026
15.01.FDA and EMA release collaborative AI framework for drug development
14.01.JPM26: Regeneron will not overpay in M&A deals amid lead asset patent expiries
14.01.JPM26: Bayer evades patent cliff in a way it may not be able to repeat
14.01.JPM26: AstraZeneca bids to accelerate oncology R&D with Modella AI acquisition